Affiliation:
1. Molecular Endocrinology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, India
2. Center for Indian Knowledge Systems, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India
Abstract
ABSTRACT
The application of Ayurvedic Bhasma in cancer treatment has garnered increasing interest due to its potential as an alternative therapeutic approach. Bhasma, a herbo-mineral formulation that consists of bioactive nanoparticles used in traditional Indian medicine, has shown promising preclinical evidence for its anticancer properties. Ayurveda, an ancient medicine system practiced in the Indian subcontinent, has successfully used various formulations to prevent or treat arbuda, which can be correlated with cancer. These formulations include Swarna Bhasma, Heerak Bhasma, Abhrak Bhasma, Manikya Bhasma, Yashada Bhasma, and many more. Using Ayurvedic medicines, the side effects of chemotherapy can be minimized, thereby increasing the life span of patients. With the advent of nanotechnology, traditional drug design and delivery are being looked upon in a completely new perspective. The anticancer activity of certain Bhasma is attributed to the presence of metallic nanoparticle content, enhancing its bioavailability and targeted action on cancer cells. In preclinical studies, some Bhasmas have demonstrated potential in inhibiting cancer cell proliferation, inducing apoptosis, and suppressing tumor growth. However, at the same time, limitations in the use of Bhasma for cancer treatment, such as the lack of standardized synthesis processes and documented scientific validation, have also been acknowledged. The multifaceted analysis presented underscores the need for rigorous research, including clinical trials, to validate the safety, efficacy, and specific applications of Bhasma in different cancer types and stages. Although the health-beneficial effects of these Bhasmas have been known for a long time, their mechanism of action is not clearly understood yet at least for some Bhasmas that have shown potential in clinical trials. Therefore, further detailed studies are needed to understand the therapeutic mode of action for different Bhasma. However, despite these limitations, the integration of Ayurvedic Bhasma into cancer treatment regimens emerges as a compelling prospect, potentially yielding synergistic effects.